RNU6-1265P

Across TCGA pan-cancer cohorts, RNU6-1265P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU6-1265P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RNU6-1265P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1265P expression acts as an unfavorable survival marker.

UVM, KIRC, and GBM are the cancer types where RNU6-1265P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.037	0.858	<.001	108	view →
KIRC	DFS	Tertile	III,IV	0.127	0.744	.002	72	view →
GBM	OS	Tertile	All	0.104	0.415	.024	18	view →
BLCA	OS	Tertile	All	0.480	0.725	.037	12	view →
COAD	OS	Tertile	III,IV	0.183	0.696	.049	9	view →
BRCA	DFS	Tertile	II,III,IV	0.172	0.522	.007	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU6-1265P–UVM (OS)

Open the UVM breakdown →